He Ren

16PUBLICATIONS
50CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosisTumour immunologyRegenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Oct 23, 2026
Cancer cell-specific FOXP3 licenses MMP19-dependent matrix remodeling and metastatic dissemination in pancreatic ductal adenocarcinoma.

|Apr 17, 2026
Temporally Programmed and Laser-Triggered Immunomodulatory Hydrogel Enables Synergistic Wound Healing and Prevention of Postoperative Tumor Recurrence.

|Jan 16, 2026
Metabolic dysfunction-associated steatotic liver disease accelerates pancreatic cancer progression and metastasis via the macrophage migration inhibitory factor-CD44 axis.

Qian Yu, Hui Song, Xiao-Ya Shi

|Jan 06, 2026
Targeting neutrophil-driven immunosuppression: A strategy to overcome immune checkpoint inhibitor resistance.

Ying Ning, Ke Lei, Xinyan Gao

|Jun 04, 2025
Risk Stratification and Prognosis Determination Based on Protein Lysine Crotonylation in Patients with Resected Pancreatic Cancer: A Multicenter Study.

Lianjing Cao, Huaxin Li, Fang Liu

|Nov 19, 2024
Label-Free Prediction of Tumor Metastatic Potential via Ramanome.

Yuxing Zhang, Yanmei Zhang, Ruining Gong

Pageof 3

Frequent Collaborators

2 joint publications

Ruining Gong

1 joint publications

He Huang

1 joint publications

Xiao Zhao

1 joint publications

Guangjun Nie